HORACEK, Jiri, Robert JANDA, Natalie GÖRNEROVA, Lucia JAJCAY and Veronika ANDRASHKO. Several reasons why ketamine as a neuroplastic agent may have failed to prevent postoperative delirium: Implications for future protocols. Neuroscience Letters. CLARE: Elsevier, 2023, vol. 798, February 20213, p. 1-4. ISSN 0304-3940. Available from: https://dx.doi.org/10.1016/j.neulet.2023.137095.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Several reasons why ketamine as a neuroplastic agent may have failed to prevent postoperative delirium: Implications for future protocols
Authors HORACEK, Jiri, Robert JANDA, Natalie GÖRNEROVA, Lucia JAJCAY and Veronika ANDRASHKO.
Edition Neuroscience Letters, CLARE, Elsevier, 2023, 0304-3940.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.500 in 2022
RIV identification code RIV/00216224:90249/23:00133576
Doi http://dx.doi.org/10.1016/j.neulet.2023.137095
UT WoS 000963146600001
Keywords (in Czech) Ketamine; Postoperative delirium; Anesthesia; Neuroprotective; Neuroplastic; Benzodiazepines; Pharmacological interaction
Keywords in English Ketamine; Postoperative delirium; Anesthesia; Neuroprotective; Neuroplastic; Benzodiazepines; Pharmacological interaction
Tags Excelence Science, neMU, NÚDZ, RIV, user, článek v časopise
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 11/4/2024 23:26.
Abstract
Ketamine exerts anti-inflammatory, neuroprotective and neuroplastic activity, therefore it may counteract the neurotoxic processes underlying postoperative delirium. However, the majority of studies in this field failed. We identified several pharmacological reasons why these studies may have failed, together with suggestions of how to remediate them. Among them, the interaction with intravenous general anesthetics exerting the opposite effect on GABA interneurons than ketamine may be of principal importance. We suggest biomarkers which may elucidate the influence of this interaction on the different steps of neuroplastic pathways. We hypothesize that administering ketamine before or after general anesthesia could both prevent the interactions and strengthen the effect of ketamine by timing surgery within the climax of ketamine-induced neuroplastic changes or by stabilizing AMPA receptors. It is vital to deal with these questions because the protocols of ongoing studies are based again on the administration of ketamine during general anesthesia (the major identified pitfall).
Links
90249, large research infrastructuresName: CZECRIN IV
PrintDisplayed: 28/6/2024 15:01